Insight Wealth Partners’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$536K Buy
2,049
+11
+0.5% +$2.82K 0.07% 85
2026
Q2
$513K Sell
2,038
-451
-18% -$97K 0.07% 85
2026
Q1
$541K Sell
2,489
-224
-8% -$49.7K 0.08% 79
2025
Q4
$620K Sell
2,713
-493
-15% -$112K 0.09% 72
2025
Q3
$742K Sell
3,206
-5
-0.2% -$1.02K 0.23% 65
2025
Q2
$596K Sell
3,211
-304
-9% -$56.5K 0.23% 64
2025
Q1
$736K Sell
3,515
-344
-9% -$66.9K 0.12% 57
2024
Q4
$686K Buy
3,859
+5
+0.1% +$919 0.09% 57
2024
Q3
$761K Buy
3,854
+4
+0.1% +$747 0.15% 52
2024
Q2
$660K Hold
3,850
– – 0.11% 52
2024
Q1
$701K Sell
3,850
-900
-19% -$155K 0.12% 46
2023
Q4
$736K Hold
4,750
– – 0.13% 44
2023
Q3
$708K Sell
4,750
-412
-8% -$60.5K 0.14% 43
2023
Q2
$695K Sell
5,162
-600
-10% -$88K 0.16% 44
2023
Q1
$918K Buy
+5,762
New +$881K 0.21% 28

Other funds holding ABBV

Insight Wealth Partners's ABBV Position: Q3 2026 in Review

Insight Wealth Partners increased its AbbVie (ABBV) stake by 0.54% in Q3 2026, buying an estimated $2.82K and bringing the position to 2,049 shares worth $536K. The position accounts for 0.07% of the portfolio, ranked #85.

Insight Wealth Partners first reported a position in ABBV in Q1 2023 and has held it in 15 quarters since. The position peaked at $918K in Q1 2023. 1,999 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Insight Wealth Partners held 2,049 shares of AbbVie worth $536K as of Q3 2026.
  • Insight Wealth Partners bought 11 AbbVie shares in Q3 2026, an estimated $2.82K.
  • AbbVie made up 0.07% of Insight Wealth Partners's portfolio in Q3 2026, its #85 holding.
  • Insight Wealth Partners first reported a position in AbbVie in Q1 2023 and has held it in 15 quarters since.
  • Insight Wealth Partners's AbbVie position peaked at $918K in Q1 2023.
  • 1,999 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Insight Wealth Partners's 13F filing for Q3 2026, filed 26 Oct 2026.